Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux

被引:4
作者
Liu, Jixin [1 ]
Wang, Qiuning [2 ]
Wei, Yujie [3 ]
Zhang, Shining [4 ]
Chai, Erqing [5 ]
Tang, Futian [3 ,4 ]
机构
[1] Gansu Prov Hosp, Dept Med, Lanzhou 730000, Peoples R China
[2] Jinzhou Med Univ, Dept Pharmacol, Jinzhou 121001, Peoples R China
[3] Lanzhou Univ, Dept Cardiovasc Dis, Hosp 2, 82,Cuiyingmen, Lanzhou 730030, Peoples R China
[4] Lanzhou Univ, Key Lab Digest Syst Tumors Gansu Prov, Hosp 2, 82,Cuiyingmen, Lanzhou 730030, Peoples R China
[5] Emergency Gen Hosp, 29,Xiba Henanli, Beijing 100028, Peoples R China
基金
中国国家自然科学基金;
关键词
Atherosclerosis; Apolipoprotein E knockout mice; Calpain inhibitor; Oxidative stress; Inflammation; Cholesterol intake and efflux; LOW-DENSITY-LIPOPROTEIN; ABDOMINAL AORTIC-ANEURYSMS; SCAVENGER RECEPTORS; DEFICIENT MICE; INFLAMMATION; OXLDL; CD36; LDL; INTERLEUKIN-6; SIMVASTATIN;
D O I
10.1016/j.mvr.2021.104276
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose: We previously reported that a calpain inhibitor (CAI) prevents the development of atherosclerosis in rats. This study aimed to investigate the effects of CAI (1 mg/kg) on atherosclerosis in apolipoprotein E knockout (ApoE KO) mice that were fed a high-fat diet (HFD) and explore the underlying mechanism by analyzing the expression of genes related to the uptake and efflux of cholesterol. Methods: Atherosclerotic plaques were evaluated. The activity of calpain in the aorta and that of superoxide dismutase (SOD) in the serum were assessed. Lipid profiles in the serum and liver were examined. Serum oxidized low-density lipoprotein (oxLDL), malondialdehyde (MDA), tumor necrosis factor (TNF-alpha), and interleukin-6 (IL-6) levels were measured. The mRNA expressions of CD68, TNF-alpha, IL-6, CD36, scavenger receptor (SR-A), peroxisome proliferator-activated receptor gamma (PPAR-gamma), liver-x-receptor alpha (LXR-alpha), and ATP-binding cassette transporter class A1 (ABCA1) in the aorta and peritoneal macrophages were also evaluated. Results: CAI reduced calpain activity in the aorta. CAI also impeded atherosclerotic lesion formation and mRNA expression of CD68 in the aorta and peritoneal macrophages of ApoE KO mice compared with those of mice receiving HFD. However, CAI had no effect on body weight and lipid levels in both the serum and liver. CAI significantly decreased MDA, oxLDL, TNF-alpha, and IL-6 levels and increased SOD activity in the serum. Moreover, CAI significantly inhibited the mRNA expression of TNF-alpha and IL-6 genes in the aorta and peritoneal macrophages. In addition, CAI significantly downregulated the mRNA expression of scavenger receptors CD36 and SRA and upregulated the expression of genes involved in the cholesterol efflux pathway, i.e., PPAR-gamma, LXR-alpha, and ABCA1 in the aorta and peritoneal macrophages. Conclusions: CAI inhibited the development of atherosclerotic lesions in ApoE KO mice, and this effect might be related to the reduction of oxidative stress and inflammation and the improvement of cholesterol intake and efflux pathways.
引用
收藏
页数:6
相关论文
共 34 条
  • [1] Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus
    Ahmad, Hamada Mohammad
    Sarhan, Esmat M.
    Komber, Usama
    [J]. RHEUMATOLOGY INTERNATIONAL, 2014, 34 (05) : 617 - 623
  • [2] Lack of IκBNS accelerates atherosclerosis in LDL receptor-deficient mice via increased interleukin-6 production
    Akita, Koji
    Isoda, Kikuo
    Okabayasi, Yayoi
    Shimada, Kazunori
    Daida, Hiroyuki
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 211 : 61 - 63
  • [3] ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS
    BERLINER, JA
    NAVAB, M
    FOGELMAN, AM
    FRANK, JS
    DEMER, LL
    EDWARDS, PA
    WATSON, AD
    LUSIS, AJ
    [J]. CIRCULATION, 1995, 91 (09) : 2488 - 2496
  • [4] Aortic Gene Expression Profiles Show How ApoA-I Levels Modulate Inflammation, Lysosomal Activity, and Sphingolipid Metabolism in Murine Atherosclerosis
    Busnelli, Marco
    Manzini, Stefano
    Chiara, Matteo
    Colombo, Alice
    Fontana, Fabrizio
    Oleari, Roberto
    Poti, Francesco
    Horner, David
    Bellosta, Stefano
    Chiesa, Giulia
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (02) : 651 - 667
  • [5] Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha
    Canault, M.
    Pelretti, F.
    Poggi, M.
    Mueller, C.
    Kopp, F.
    Bonardo, B.
    Bastelica, D.
    Nicolay, A.
    Alessi, M-C
    Nalbone, G.
    [J]. JOURNAL OF PATHOLOGY, 2008, 214 (05) : 574 - 583
  • [6] A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
    Chawla, A
    Boisvert, WA
    Lee, CH
    Laffitte, BA
    Barak, Y
    Joseph, SB
    Liao, D
    Nagy, L
    Edwards, PA
    Curtiss, LK
    Evans, RM
    Tontonoz, P
    [J]. MOLECULAR CELL, 2001, 7 (01) : 161 - 171
  • [7] The oxidative modification hypothesis of atherogenesis: An overview
    Chisolm, GM
    Steinberg, D
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) : 1815 - 1826
  • [8] Macrophage scavenger receptors and foam cell formation
    de Villiers, WJS
    Smart, EJ
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (05) : 740 - 746
  • [9] Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis
    Di Pietro, Natalia
    Formoso, Gloria
    Pandolfi, Assunta
    [J]. VASCULAR PHARMACOLOGY, 2016, 84 : 1 - 7
  • [10] Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromso Study
    Eltoft, Agnethe
    Arntzen, Kjell Arne
    Wilsgaard, Tom
    Mathiesen, Ellisiv B.
    Johnsen, Stein Harald
    [J]. ATHEROSCLEROSIS, 2018, 271 : 1 - 8